Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
The webcast will also be available on the Investor Relations/Audio Archives page of the Company's website, www.neose.com.
Neose Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development of next-generation therapeutic proteins that are competitive with best-in-class protein drugs currently on the market, on its own and through strategic partnerships. The lead candidates in its pipeline, NE-180 for use in the treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure and GlycoPEG-GCSF for chemotherapy-induced neutropenia, target markets with aggregate sales in excess of $15 billion.
For more information, please visit www.neose.com.
Neose Technologies, Inc.
A. Brian Davis
Sr. Vice President and Chief Financial Officer
Manager, Corporate Communications
Posted: July 2007